---
title: "Zhongxing BioTech provides guarantees for its subsidiaries, with a cumulative guarantee balance exceeding 1.1 billion yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261391264.md"
description: "Zhongxing BioTech announced on October 16, 2025, that it would provide a guarantee limit of no more than 1.97 billion yuan for certain wholly-owned subsidiaries. To meet funding needs, Jiangsu Zhongxing applied for a loan of 350 million yuan from Jiangsu Bank, and Zhongxing BioTech provided a joint liability guarantee for it; Hubei Zhongxing applied for a loan of no more than 40 million yuan from China Construction Bank, and Zhongxing BioTech also provided a guarantee. As of the announcement date, the total guarantee balance for subsidiaries within the scope of the consolidated financial statements was 1.152 billion yuan, accounting for 34.73% of the net assets for the fiscal year 2024"
datetime: "2025-10-16T08:19:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261391264.md)
  - [en](https://longbridge.com/en/news/261391264.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261391264.md)
generator: "portal-rs"
---

# Zhongxing BioTech provides guarantees for its subsidiaries, with a cumulative guarantee balance exceeding 1.1 billion yuan

On October 16, 2025, Zhongxing BioTech announced the progress of external guarantees. In 2024, the relevant meeting approved the proposal to provide a guarantee limit of no more than 1.97 billion yuan for some wholly-owned subsidiaries for the year 2025. This time, to meet funding needs, Jiangsu Zhongxing applied for a loan of 350 million yuan from Jiangsu Bank, and on October 14, Zhongxing BioTech provided a joint liability guarantee for it; Hubei Zhongxing applied for a loan from China Construction Bank, and on the same day, Zhongxing BioTech provided a joint liability guarantee of no more than 40 million yuan for it. As of the announcement date, the total balance of external guarantees provided by the company for subsidiaries and wholly-owned subsidiaries within the scope of the consolidated financial statements was 1.152 billion yuan, accounting for 34.73% of the audited net assets attributable to shareholders of the listed company for the year 2024, with no overdue or abnormal guarantee situations

### Related Stocks

- [002772.CN](https://longbridge.com/en/quote/002772.CN.md)

## Related News & Research

- [Uniao Pet Participacoes: Grupo Petz Cobasi drives growth in Brazil's booming pet market with omnichannel leadership and synergy gains](https://longbridge.com/en/news/297552330.md)
- [UK fintech Allica Bank looks to crack European market](https://longbridge.com/en/news/297498349.md)
- [BW ESS buys 126-MW Spanish battery storage projects from Navacant](https://longbridge.com/en/news/297744603.md)
- [Motus FY26 earnings per share rise 19% to 1,753 cents; revenue climbs 1% to ZAR 113.55 billion](https://longbridge.com/en/news/297734398.md)
- [BYD deepens PaXini ties, opens auto factories to robots](https://longbridge.com/en/news/297518424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**